← Back to Knowledge Base

Primary topic: PCSK9 LDL regulation gene

PCSK9 Gene and Metabolism: What It Can Mean in a Pathway Report

PCSK9 helps regulate how many LDL receptors remain available to clear LDL particles from circulation.

What is the PCSK9 gene?

PCSK9 binds LDL receptors and promotes their removal. Lower PCSK9 activity can leave more LDL receptors available, while higher effective activity can reduce LDL receptor availability.

How PCSK9 affects metabolism

PCSK9-linked variants are interpreted through LDL-C, ApoB, and LDL receptor regulation. The report treats this as lipid pathway context, not medication advice.

What happens when PCSK9 is altered

A PCSK9 signal does not diagnose lipid disease. It makes LDL particle markers worth checking if the broader lipid pathway is active.

Curated SNP evidence for PCSK9

These SNPs come from the approved study-level evidence model. Each claim is scored from curated study rows, then gated before it can influence pathway scoring.

Evidence-backed report connection

PCSK9 currently has 2 curated SNPs, 2 claim-level scores, and 1 claims eligible for pathway scoring.

Open the sample report
rs11591147R46L1 claims · 1 study rows

biomarker tendency · T

LDL cholesterol tendency

Not used for pathway scoring

rs11591147 T is associated with lower LDL cholesterol tendency as a PCSK9 loss-of-function proxy.

PCSK9 rs11591147 T is staged as a lipid biomarker-lowering allele, not as a cardiovascular disease-risk estimate.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportModerate support
Report useEvidence only, not scored
Show study evidence
rs562556PCSK9 LDL-C supporting signal1 claims · 2 study rows

biomarker tendency · AG

PCSK9-linked LDL cholesterol tendency

Moderate

rs562556 AG carries one PCSK9 rs562556 G allele and is associated with lower LDL cholesterol tendency.

PCSK9 rs562556 AG is staged as a heterozygous LDL-C-lowering tendency signal.

Likely effectLower biomarker tendency
Signal sizeSmall signal
Evidence supportStrong support
Report useIncluded in pathway scoring
Show study evidence

Common symptoms people report

  • family context around LDL cholesterol
  • unexpected ApoB or LDL-C patterns
  • lipid results that do not match diet or activity alone

Biomarkers to validate

ApoB

Shows atherogenic particle number more directly than total cholesterol.

LDL-C

Tracks the cholesterol carried in LDL particles.

Lipid panel

Provides HDL-C, triglycerides, and total cholesterol context.

Where DNA analysis helps

DNA helps decide whether LDL receptor regulation deserves attention inside the broader Lipids pathway.

Example interpretation

PCSK9 may add useful context when its SNP evidence lines up with the broader pathway signal.

Suggested validation: ApoB and LDL-C.

What to do next

  • Check ApoB and LDL-C before interpreting the gene alone.
  • Compare PCSK9 with LDLR, APOE, and lifestyle context.
  • Use clinician guidance for medication questions.

Upload your DNA file and receive a structured metabolic pathway analysis with prioritized insights and suggested validation markers.

Get My DNA Report

Related pages